
BioMedicure was invited as a guest to participate in the 2014 China Dalian International Translational Medicine Cooperation Summit.
The 2014 China Dalian International Translational Medicine Cooperation Summit, hosted by the State Administration of Foreign Experts Affairs Foreign Talent Information Research Center and organized by BioTai International Conference (Dalian) Co., Ltd., was grandly held in Dalian from June 26 to 28, 2014. Dr. Qian Yong, Chairman of BioMedicure (Shanghai) Biotechnology Co., Ltd., attended as a special guest and delivered an excellent report at the conference, conveying the cutting-edge technology and research achievements of ATATES to the world. Dr. Qian explained how the ATATES new antigen product fully activates both the innate and adaptive immune responses, upgrading the immune system... making cancer cure possible.